1
|
Lindner AK, Lejon V, Barrett MP, Blumberg L, Bukachi SA, Chancey RJ, Edielu A, Matemba L, Mesha T, Mwanakasale V, Pasi C, Phiri T, Seixas J, Akl EA, Probyn K, Villanueva G, Simarro PP, Kadima Ebeja A, Franco JR, Priotto G. New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine. THE LANCET. INFECTIOUS DISEASES 2024:S1473-3099(24)00581-4. [PMID: 39389073 DOI: 10.1016/s1473-3099(24)00581-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Revised: 08/24/2024] [Accepted: 08/27/2024] [Indexed: 10/12/2024]
Abstract
Human African trypanosomiasis is a neglected tropical disease that is usually fatal without treatment. WHO has revised its rhodesiense human African trypanosomiasis treatment guidelines on the basis of an independent systematic literature review and following the GRADE methodology. This Review reports on the decision-making process and summarises the new recommendations and their potential implications for health-care professionals and policy makers. Due to data scarcity, all recommendations are conditional and based on very low certainty of evidence. Fexinidazole replaces suramin and melarsoprol as the first-line therapy in individuals aged 6 years and older with a bodyweight of 20 kg or more. As fexinidazole is effective in both stages of rhodesiense human African trypanosomiasis, a lumbar puncture for staging is no longer required. In settings in which first-choice drugs are not readily available, immediate interim treatment with pentamidine is suggested. The introduction of oral fexinidazole represents an advancement in the management of rhodesiense human African trypanosomiasis considering the life-threatening adverse reactions individuals can have to melarsoprol. However, children below the age or weight limits remain ineligible for treatment with fexinidazole.
Collapse
Affiliation(s)
- Andreas K Lindner
- Charité-Universitätsmedizin Berlin, Charité Center for Global Health, Institute of International Health, Berlin, Germany.
| | - Veerle Lejon
- Intertryp, Institut de Recherche pour le Développement, CIRAD, University of Montpellier, Montpellier, France
| | - Michael P Barrett
- School of Infection and Immunity, University of Glasgow, Glasgow, UK
| | - Lucille Blumberg
- National Institute for Communicable Diseases, Johannesburg, South Africa
| | - Salome A Bukachi
- Institute of Anthropology, Gender and African Studies, University of Nairobi, Nairobi, Kenya; Department of Anthropology, Durham University, Durham, UK
| | | | - Andrew Edielu
- Immunomodulation and Vaccines Theme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda
| | - Lucas Matemba
- National Institute for Medical Research, Dodoma, Tanzania
| | | | | | | | | | - Jorge Seixas
- Institute of Hygiene and Tropical Medicine and Global Health and Tropical Medicine R&D Center, NOVA University, Lisbon, Portugal
| | - Elie A Akl
- Department of Internal Medicine, American University of Beirut, Beirut, Lebanon; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
| | | | | | - Pere P Simarro
- World Health Organization, Global Neglected Tropical Diseases Programme, Prevention, Treatment and Care Unit, Geneva, Switzerland
| | - Augustin Kadima Ebeja
- World Health Organization Office for the Democratic Republic of the Congo, Kinshasa, Democratic Republic of the Congo
| | - Jose R Franco
- Neglected Tropical Diseases Department, World Health Organization, Geneva, Switzerland
| | - Gerardo Priotto
- Neglected Tropical Diseases Department, World Health Organization, Geneva, Switzerland
| |
Collapse
|
2
|
Kabanga C, Valverde Mordt O, Mbo F, Mbondo M, Olela D, Etinkum R, Nkaji D, Mukoso B, Mananasi L. Communities' Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo. Diseases 2022; 10:69. [PMID: 36278568 PMCID: PMC9589976 DOI: 10.3390/diseases10040069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 09/16/2022] [Accepted: 09/20/2022] [Indexed: 09/07/2024] Open
Abstract
BACKGROUND The number of human African trypanosomiasis (HAT) cases in the Democratic Republic of Congo (DRC) has significantly reduced, thanks to more effective drugs and screening tools and regular mass screening. However, this potentially jeopardizes HAT control activities, especially community engagement. METHODS We used an ecological model framework to understand how various factors shape communities' knowledge, perceptions, and behavior in this low endemicity context. Community members, frontline health providers, and policymakers were consulted using an ethnographic approach. RESULTS Communities in endemic areas are knowledgeable about causes, symptoms, and treatment of HAT, but this was more limited among young people. Few are aware of new HAT treatment or screening techniques. Participation in mass screening has declined due to many factors including fear and a lack of urgency, given the low numbers of cases. Delays in seeking medical care are due to confusion of HAT symptoms with those of other diseases and belief that HAT is caused by witchcraft. CONCLUSIONS Community members see their role more in terms of vector control than participation in screening, referral, or accepting treatment. We propose recommendations for achieving sustainable community engagement, including development of an information and communication strategy and empowerment of communities to take greater ownership of HAT control activities.
Collapse
Affiliation(s)
| | | | - Florent Mbo
- Drugs for Neglected Diseases initiative, Quartier Socimat, Gombe, Kinshasa, Democratic Republic of the Congo
| | - Medard Mbondo
- Independent Consultant, Quartier Ngansele, Mont Ngafula, Kinshasa, Democratic Republic of the Congo
| | - Donatien Olela
- Faculty of Social, Politic and Administrative Sciences, Department of Sociology, University of Kinshasa, Kinshasa P.O. Box 127, Democratic Republic of the Congo
| | - Rinelle Etinkum
- Deutsche Gesellschaft für Internationale Zusammenarbeit, Gombe, Kinshasa P.O. Box 7555, Democratic Republic of the Congo
| | - Dieudonne Nkaji
- Faculty of Social, Politic and Administrative Sciences, Department of Anthropology, University of Kinshasa, Kinshasa P.O. Box 127, Democratic Republic of the Congo
| | - Bienvenu Mukoso
- Faculty of Social, Politic and Administrative Sciences, Department of Anthropology, University of Kinshasa, Kinshasa P.O. Box 127, Democratic Republic of the Congo
| | - Lubanza Mananasi
- Faculty of Social, Politic and Administrative Sciences, Department of Anthropology, University of Kinshasa, Kinshasa P.O. Box 127, Democratic Republic of the Congo
| |
Collapse
|
3
|
Valverde Mordt O, Tarral A, Strub-Wourgaft N. Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program. Am J Trop Med Hyg 2022; 106:61-66. [PMID: 35292581 PMCID: PMC9154641 DOI: 10.4269/ajtmh.21-1176] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Accepted: 12/18/2021] [Indexed: 12/27/2022] Open
Abstract
In this article, the authors show the strategy used to streamline the introduction of fexinidazole, the first all oral treatment of human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense. The dose range was determined in phase 1 studies and a significant food effect was observed, which was tested with field-adapted meals. The pharmacokinetic profile required definition of a higher loading dosage for the first 4 days and administration of the daily dose together with a typical local meal to optimize product absorption and rapidly achieve drug steady state. This allowed for a combined phase II/III pivotal study directly after phase I trials. Partnerships with highly engaged actors from endemic country control programs and international research institutions started early through the HAT platform, building on an agreed target product profile (TPP), establishing a regulatory plan early and transparently including endemic countries in the research and data flow. A key element that enabled a quick start to access activities was preparing for World Health Organization guidelines early and starting the process prior to registration. Distribution plans were identified and supply was established from the start, by taking advantage of the existing supply agreement between the producers of all HAT drugs (Sanofi and Bayer) and the WHO. Pharmacovigilance and phase 4 studies were nested into wider implementation activities. Targeted sequential introduction into national programs was prioritized, based on medical need and epidemiologically updated information.
Collapse
Affiliation(s)
| | - Antoine Tarral
- Drugs for Neglected Diseases initiative, Geneva, Switzerland
| | | |
Collapse
|
4
|
Policy and Linkages in the Application of a One Health System for Reporting and Controlling African Trypanosomiasis and Other Zoonotic Diseases in Zambia. Pathogens 2021; 11:pathogens11010030. [PMID: 35055978 PMCID: PMC8781336 DOI: 10.3390/pathogens11010030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Revised: 12/24/2021] [Accepted: 12/26/2021] [Indexed: 12/02/2022] Open
Abstract
The capacity to detect, control and manage emerging and re-emerging zoonotic diseases in Africa has been limited by a lack of utilisation of available reporting structures and policies to support programmes at national and local levels. This study explored the impact of the Zambian government policies on animal and human disease reporting and management and on One Health opportunities. An in-depth review and analysis of strengths, weaknesses, opportunities, and threats in the existing policies and reporting structures in the departments responsible for Veterinary Services, Health, and Wildlife, was conducted. According to our findings, sub-optimal implementation of existing policies related to the control of zoonotic diseases was impacting disease reporting, and reporting structures play an important role in effective and sustainable reporting of zoonotic diseases. Further, the study explored capacities and strategies in trypanosomiasis control as a case study that could prompt effective adoption of a One Health approach, and as such, the study suggests measures that could help to assess the performance of a One Health system in the control of African trypanosomiasis and other zoonotic diseases.
Collapse
|
5
|
Vahekeni N, Neto PM, Kayimbo MK, Mäser P, Josenando T, da Costa E, Falquet J, van Eeuwijk P. Use of herbal remedies in the management of sleeping sickness in four northern provinces of Angola. JOURNAL OF ETHNOPHARMACOLOGY 2020; 256:112382. [PMID: 31743767 DOI: 10.1016/j.jep.2019.112382] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2019] [Revised: 11/02/2019] [Accepted: 11/10/2019] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE This study reports for the first time on the use of folk medicine to treat sleeping sickness and its symptoms in four endemic provinces in northern Angola. By interviewing both traditional practitioners and confirmed patients, it highlights reasons to recourse to folk medicine, the plant species used for this affection as well as arises awareness about the use of particular plants showing potential risks. AIM OF THE STUDY The aims of this explorative study were three-fold. Firstly, it informed on access to, and use of plant-based medicine as first-choice treatment by infected persons. Secondly, it aimed at collecting comprehensive data from patients and traditional healers on herbal remedies in order to identify plant species used in the management of the disease. Thirdly, it served as contribution for primary indication of potential risk of use associated with the studied plants and their preparation. MATERIALS AND METHODS The study was conducted in 4 endemic provinces of Angola, namely Bengo, Zaire, Kwanza Norte and Uíge. We explored the use of herbal remedies by conducting structured and semi-structured interviews within two distinct study populations. The first group comprises 30 patients who had been diagnosed for trypanosomiasis and treated by the reference treatment. The second group included 9 traditional practitioners who had already treated sleeping sickness. The plants that were cited during the interviews were collected during field walks under supervision of a traditional healer, then authenticated and deposited at the National Herbarium in Luanda. RESULTS Of the 30 included patients, 12 (40%) had turned to folk medicine in the management of trypanosomiasis and related symptoms. 7 medicinal plants were reported by this group. Considering the key motivation to consult a traditional practitioner, two main factors accounted for half of the cases: "past experience with folk medicine" and "family habit". Out of 9 traditional practitioners' interviewees, 26 medicinal plants were cited. Roots and leaves were the most used plant parts, and decoction was the common mode of preparation. Evidence for antitrypanosomal activity in the scientific literature was found for 56% (17 of 30) of the identified plant species. The most cited plant was Crossopteryx febrifuga (UR = 6). Some of the cited plants, as for example Aristolochia gigantea, raised concern about potential toxicity. CONCLUSIONS With 40% of infected persons having turned first to folk medicine before consulting a medical doctor, this explorative study points out that plant-based medicines play an important role in local dynamics of health care. It highlights the need for primary assessment of potential risk of use related to the herbal recipes, and for reporting it to the concerned population. This first ethnobotanical study on trypanosomiasis in endemic provinces of Angola provides information on 30 plants, of which some had been identified as promising for further pharmacological research. Our results provide a first step towards the validation and valorization of Angolan herbal remedies for sleeping sickness.
Collapse
Affiliation(s)
- Nina Vahekeni
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Nacional Center of Scientific Investigation (CNIC), Luanda, Angola.
| | - Pedro Menezes Neto
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Pascal Mäser
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
| | - Théophile Josenando
- Instituto de Combate e Controlo das Tripanossomíasses (ICCT), Luanda, Angola.
| | - Esperança da Costa
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Peter van Eeuwijk
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Institute of Social Anthropology, University of Basel, Münsterplatz 19, 4051, Basel, Switzerland.
| |
Collapse
|
6
|
New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice. THE LANCET. INFECTIOUS DISEASES 2020; 20:e38-e46. [DOI: 10.1016/s1473-3099(19)30612-7] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2019] [Revised: 09/30/2019] [Accepted: 10/15/2019] [Indexed: 12/18/2022]
|
7
|
Lee SJ, Apio RJ, Palmer JJ. Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among T. b. rhodesiense Human African Trypanosomiasis Patients in Uganda. Trop Med Infect Dis 2020; 5:tropicalmed5010016. [PMID: 31973101 PMCID: PMC7157203 DOI: 10.3390/tropicalmed5010016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Revised: 01/10/2020] [Accepted: 01/13/2020] [Indexed: 02/05/2023] Open
Abstract
The recent approval of fexinidazole for human African trypanosomiasis (HAT) caused by T. b. gambiense enables improved patient management that is pivotal to elimination. Effective in both the early and late stages of the disease, it obviates the need for invasive lumbar punctures which guide therapy, in some patients. Unlike existing injectable treatments requiring systematic hospitalisation, fexinidazole’s oral administration will allow many patients to be treated in an outpatient or home-based setting. Drawing on interviews with 25 T. b. rhodesiense HAT patients managed under existing protocols in Uganda where trials of fexinidazole will begin shortly, this article explores patient expectations of the new protocol to help HAT programmes anticipate patient concerns. Alongside frightening symptoms of this life-threatening illness, the pain and anxiety associated with lumbar punctures and intravenous injections of melarsoprol contributed to a perception of HAT as a serious illness requiring expert medical care. While preferring a new protocol that would avoid these uncomfortable procedures, patients’ trust in the care they received meant that nearly half were hesitant towards shifting care out of the hospital setting. Clinical observation is an important aspect of existing HAT care for patients. Programmes may need to offer extensive counselling and monitoring support before patients are comfortable accepting care outside of hospitals.
Collapse
Affiliation(s)
- Shona J Lee
- Department of Global Health & Development, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1H 9SH, UK;
- Correspondence: ; Tel.: +44-77060-46495
| | | | - Jennifer J Palmer
- Department of Global Health & Development, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1H 9SH, UK;
- Centre of African Studies, University of Edinburgh, 15a George Square, Edinburgh EH8 9LD, UK
| |
Collapse
|
8
|
Davis CN, Rock KS, Mwamba Miaka E, Keeling MJ. Village-scale persistence and elimination of gambiense human African trypanosomiasis. PLoS Negl Trop Dis 2019; 13:e0007838. [PMID: 31658269 PMCID: PMC6837580 DOI: 10.1371/journal.pntd.0007838] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Revised: 11/07/2019] [Accepted: 10/10/2019] [Indexed: 11/18/2022] Open
Abstract
Gambiense human African trypanosomiasis (gHAT) is one of several neglected tropical diseases that is targeted for elimination by the World Health Organization. Recent years have seen a substantial decline in the number of globally reported cases, largely driven by an intensive process of screening and treatment. However, this infection is highly focal, continuing to persist at low prevalence even in small populations. Regional elimination, and ultimately global eradication, rests on understanding the dynamics and persistence of this infection at the local population scale. Here we develop a stochastic model of gHAT dynamics, which is underpinned by screening and reporting data from one of the highest gHAT incidence regions, Kwilu Province, in the Democratic Republic of Congo. We use this model to explore the persistence of gHAT in villages of different population sizes and subject to different patterns of screening. Our models demonstrate that infection is expected to persist for long periods even in relatively small isolated populations. We further use the model to assess the risk of recrudescence following local elimination and consider how failing to detect cases during active screening events informs the probability of elimination. These quantitative results provide insights for public health policy in the region, particularly highlighting the difficulties in achieving and measuring the 2030 elimination goal.
Collapse
Affiliation(s)
- Christopher N. Davis
- MathSys CDT, Mathematics Institute, University of Warwick, Coventry, United Kingdom
- Zeeman Institute (SBIDER), University of Warwick, Coventry, United Kingdom
| | - Kat S. Rock
- Zeeman Institute (SBIDER), University of Warwick, Coventry, United Kingdom
- Mathematics Institute, University of Warwick, Coventry, United Kingdom
| | - Erick Mwamba Miaka
- Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Ave Coisement Liberation et Bd Triomphal No 1, Commune de Kasavubu, Kinshasa, Demecratic Republic of the Congo
| | - Matt J. Keeling
- Zeeman Institute (SBIDER), University of Warwick, Coventry, United Kingdom
- Mathematics Institute, University of Warwick, Coventry, United Kingdom
- School of Life Sciences, University of Warwick, Coventry, United Kingdom
- * E-mail:
| |
Collapse
|
9
|
Picado A, Nogaro S, Cruz I, Biéler S, Ruckstuhl L, Bastow J, Ndung’u JM. Access to prompt diagnosis: The missing link in preventing mental health disorders associated with neglected tropical diseases. PLoS Negl Trop Dis 2019; 13:e0007679. [PMID: 31622340 PMCID: PMC6797081 DOI: 10.1371/journal.pntd.0007679] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Affiliation(s)
- Albert Picado
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
- * E-mail:
| | - Sarah Nogaro
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
| | - Israel Cruz
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
- National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Sylvain Biéler
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
| | - Laura Ruckstuhl
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
| | - Jon Bastow
- Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
| | | |
Collapse
|
10
|
Selby R, Wamboga C, Erphas O, Mugenyi A, Jamonneau V, Waiswa C, Torr SJ, Lehane M. Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target? PLoS Negl Trop Dis 2019; 13:e0007550. [PMID: 31412035 PMCID: PMC6693741 DOI: 10.1371/journal.pntd.0007550] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2018] [Accepted: 06/13/2019] [Indexed: 01/28/2023] Open
Abstract
In 1994, combined active and passive screening reported 1469 cases from the historic Gambian Human African Trypanosomiasis (gHAT) foci of West Nile, Uganda. Since 2011 systematic active screening has stopped and there has been reliance on passive screening. During 2014, passive screening alone detected just nine cases. In the same year a tsetse control intervention was expanded to cover the main gHAT foci in West Nile to curtail transmission of gHAT contributing to the elimination of gHAT as a public health problem in the area. It is known that sole reliance on passive screening is slow to detect cases and can underestimate the actual true number. We therefore undertook an active screening programme designed to test the efficacy of these interventions against gHAT transmission and clarify disease status. Screening was conducted in 28 randomly selected villages throughout the study area, aiming to sample all residents. Whole blood from 10,963 participants was analysed using CATT and 97 CATT suspects (0.9%) were evaluated with microscopy and trypanolysis. No confirmed cases were found providing evidence that the gHAT prevention programmes in West Nile have been effective. Results confirm gHAT prevalence in the study area of West Nile is below the elimination threshold (1 new case / 10,000 population), making elimination on course across this study area if status is maintained. The findings of this study can be used to guide future HAT and tsetse management in other gHAT foci, where reduced caseloads necessitate a shift from active to passive screening. The number of gHAT cases across West Nile, Uganda has declined in the last 20 years. This decline is due to the impact of programmes of active and passive case detection and treatment which have recently been combined with tsetse control operations (post 2011). We carried out an active survey of gHAT to evaluate the prevalence in areas where vector control has been introduced. Our results confirm that the overall prevalence of gHAT is below 1 case per 10,000 people at risk in the historical foci and shows that results from passive screening are providing an accurate picture of gHAT prevalence in the area.
Collapse
Affiliation(s)
- Richard Selby
- Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom
- * E-mail:
| | - Charles Wamboga
- Vector Control Division, Ministry of Health, Wandegeya, Kampala, Uganda
| | - Olema Erphas
- Vector Control Division, Ministry of Health, Wandegeya, Kampala, Uganda
| | - Albert Mugenyi
- Co-ordinating Office for Control of Trypanosomiasis Uganda, Wandegeya, Kampala, Uganda
| | - Vincent Jamonneau
- UMR 177 Intertryp, Institut de Recherche pour le Développement (IRD), Montpellier, France
| | - Charles Waiswa
- Co-ordinating Office for Control of Trypanosomiasis Uganda, Wandegeya, Kampala, Uganda
| | - Steve J. Torr
- Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom
| | - Michael Lehane
- Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom
| |
Collapse
|
11
|
Merritt MW, Sutherland CS, Tediosi F. Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for Trypanosoma brucei gambiense. Public Health Ethics 2018; 11:275-292. [PMID: 30429873 PMCID: PMC6225893 DOI: 10.1093/phe/phy013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
We sought to assess formally the extent to which different control and elimination strategies for human African trypanosomiasis Trypanosoma brucei gambiense (Gambiense HAT) would exacerbate or alleviate experiences of societal disadvantage that traditional economic evaluation does not take into account. Justice-enhanced cost-effectiveness analysis (JE-CEA) is a normative approach under development to address social justice considerations in public health decision-making alongside other types of analyses. It aims to assess how public health interventions under analysis in comparative evaluation would be expected to influence the clustering of disadvantage across three core dimensions of well-being: agency, association and respect. As a case study to test the approach, we applied it to five strategies for Gambiense HAT control and elimination, in combination with two different other evaluations: a cost-effectiveness analysis and a probability of elimination analysis. We have demonstrated how JE-CEA highlights the ethical importance of adverse social justice impacts of otherwise attractive options and how it indicates specific modifications to policy options to mitigate such impacts. JE-CEA holds promise as an approach to help decision makers and other stakeholders consider social justice more fully, explicitly and systematically in evaluating public health programs.
Collapse
Affiliation(s)
- Maria W Merritt
- Johns Hopkins Berman Institute of Bioethics and Department of International Health, Johns Hopkins Bloomberg School of Public Health
| | | | - Fabrizio Tediosi
- Swiss Tropical and Public Health Institute and Universität Basel
| |
Collapse
|
12
|
Bukachi SA, Mumbo AA, Alak ACD, Sebit W, Rumunu J, Biéler S, Ndung'u JM. Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan. PLoS Negl Trop Dis 2018; 12:e0006826. [PMID: 30273342 PMCID: PMC6181432 DOI: 10.1371/journal.pntd.0006826] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Revised: 10/11/2018] [Accepted: 09/11/2018] [Indexed: 02/01/2023] Open
Abstract
Background A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primary healthcare. Knowledge and awareness on HAT, its new/improved screening and diagnostic tools, the places and processes of getting a confirmatory diagnosis and treatment are crucial to the success of this strategy. Methodology A KAP survey was carried out in Yei County, South Sudan, to identify gaps in community KAP and determine the preferred channels and sources of information on the disease. The cross-sectional KAP survey utilized questionnaires, complemented with key informant interviews and a focus group discussion to elicit communal as well as individual KAP on HAT. Findings Most (90%) of the respondents had general knowledge on HAT. Lower levels of education, gender and geographic locations without a history of HAT interventions were associated with incorrect knowledge and/or negative perceptions about the treatability of HAT. Symptoms appearing in the late stage were best known. A majority (97.2%) would seek treatment for HAT only in a health centre. However, qualitative data indicates that existing myths circulating in the popular imagination could influence people’s practices. Seventy-one percent of the respondents said they would offer social support to patients with HAT but qualitative data highlights that stigma still exists. Misconceptions and stigma can negatively influence the health seeking behaviour of HAT cases. In relation to communication, the top preferred and effective source of communication was radio (24%). Conclusion Gaps in relation to KAP on HAT still exist in the community. Perceptions on HAT, specifically myths and stigma, were key gaps that need to be bridged through effective education and communication strategies for HAT control alongside other interventions. Misconceptions about sleeping sickness, a neglected tropical disease transmitted by tsetse flies, can be a hindrance to effective implementation of control interventions especially in the face of accelerating work to eliminate the disease. Understanding community knowledge, attitudes and practices about sleeping sickness is important in developing appropriate material for educating and sensitizing communities at risk of the disease. We conducted a study to establish community knowledge, attitudes and practices, including preferred channels of disseminating sleeping sickness information. Despite the fact that the community in Yei County knew about the disease, existing myths and stigma have the potential of influencing their health seeking behaviour. The radio, community health workers and village elders were the most preferred sources of sharing information with the community. There is need to develop education and awareness material to address issues of existing myths, potential stigma, treat ability of HAT, importance of testing and treatment, as well as provide information on the new/improved testing and treatment approaches for HAT. In addition, this should be provided through use of preferred and trusted sources of information dissemination, which is critical in uptake of HAT control, management and prevention activities.
Collapse
Affiliation(s)
- Salome A. Bukachi
- Institute of Anthropology, Gender and African Studies, University of Nairobi, Nairobi, Kenya
- Research and Development, Passion Africa Limited, Nairobi, Kenya
- * E-mail:
| | - Angeline A. Mumbo
- South Sudan Coordination Office, Malteser International, Juba, Republic of South Sudan
| | - Ayak C. D. Alak
- Preventive Health Services, Ministry of Health, Juba, Republic of South Sudan
| | - Wilson Sebit
- Preventive Health Services, Ministry of Health, Juba, Republic of South Sudan
| | - John Rumunu
- Preventive Health Services, Ministry of Health, Juba, Republic of South Sudan
| | - Sylvain Biéler
- Neglected Tropical Diseases, Foundation for Innovative New Diagnostics, Geneva, Switzerland
| | - Joseph M. Ndung'u
- Neglected Tropical Diseases, Foundation for Innovative New Diagnostics, Geneva, Switzerland
| |
Collapse
|
13
|
Sunyoto T, Adam GK, Atia AM, Hamid Y, Babiker RA, Abdelrahman N, Vander Kelen C, Ritmeijer K, Alcoba G, den Boer M, Picado A, Boelaert M. " Kala-Azar is a Dishonest Disease": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan. Am J Trop Med Hyg 2018; 98:1091-1101. [PMID: 29488462 PMCID: PMC5928836 DOI: 10.4269/ajtmh.17-0872] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Early diagnosis and treatment is the principal strategy to control visceral leishmaniasis (VL), or kala-azar in East Africa. As VL strikes remote rural, sparsely populated areas, kala-azar care might not be accessed optimally or timely. We conducted a qualitative study to explore access barriers in a longstanding kala-azar endemic area in southern Gadarif, Sudan. Former kala-azar patients or caretakers, community leaders, and health-care providers were purposively sampled and thematic data analysis was used. Our study participants revealed the multitude of difficulties faced when seeking care. The disease is well known in the area, yet misconceptions about causes and transmission persist. The care-seeking itineraries were not always straightforward: “shopping around” for treatments are common, partly linked to difficulties in diagnosing kala-azar. Kala-azar is perceived to be “hiding,” requiring multiple tests and other diseases must be treated first. Negative perceptions on quality of care in the public hospitals prevail, with the unavailability of drugs or staff as the main concern. Delay to seek care remains predominantly linked to economic constraint: albeit treatment is for free, patients have to pay out of pocket for everything else, pushing families further into poverty. Despite increased efforts to tackle the disease over the years, access to quality kala-azar care in this rural Sudanese context remains problematic. The barriers explored in this study are a compelling reminder of the need to boost efforts to address these barriers.
Collapse
Affiliation(s)
- Temmy Sunyoto
- Institute of Tropical Medicine, Antwerp, Belgium.,Médecins Sans Frontières Campaign for Access to Medicines, Geneva, Switzerland
| | - Gamal K Adam
- Faculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan
| | - Atia M Atia
- Faculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan
| | - Yassin Hamid
- Faculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan
| | - Rabie Ali Babiker
- Faculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan
| | - Nugdalla Abdelrahman
- Faculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan
| | | | | | | | - Margriet den Boer
- KalaCORE Consortium, London, United Kingdom.,Médecins Sans Frontières, Amsterdam, The Netherlands
| | - Albert Picado
- ISGlobal, Barcelona Institute of Global Health, Barcelona, Spain
| | | |
Collapse
|
14
|
Rock KS, Torr SJ, Lumbala C, Keeling MJ. Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo. PLoS Negl Trop Dis 2017; 11:e0005162. [PMID: 28056016 PMCID: PMC5215767 DOI: 10.1371/journal.pntd.0005162] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Accepted: 11/04/2016] [Indexed: 01/24/2023] Open
Abstract
Two goals have been set for Gambian human African trypanosomiasis (HAT), the first is to achieve elimination as a public health problem in 90% of foci by 2020, and the second is to achieve zero transmission globally by 2030. It remains unclear if certain HAT hotspots could achieve elimination as a public health problem by 2020 and, of greater concern, it appears that current interventions to control HAT in these areas may not be sufficient to achieve zero transmission by 2030. A mathematical model of disease dynamics was used to assess the potential impact of changing the intervention strategy in two high-endemicity health zones of Kwilu province, Democratic Republic of Congo. Six key strategies and twelve variations were considered which covered a range of recruitment strategies for screening and vector control. It was found that effectiveness of HAT screening could be improved by increasing effort to recruit high-risk groups for screening. Furthermore, seven proposed strategies which included vector control were predicted to be sufficient to achieve an incidence of less than 1 reported case per 10,000 people by 2020 in the study region. All vector control strategies simulated reduced transmission enough to meet the 2030 goal, even if vector control was only moderately effective (60% tsetse population reduction). At this level of control the full elimination threshold was expected to be met within six years following the start of the change in strategy and over 6000 additional cases would be averted between 2017 and 2030 compared to current screening alone. It is recommended that a two-pronged strategy including both enhanced active screening and tsetse control is implemented in this region and in other persistent HAT foci to ensure the success of the control programme and meet the 2030 elimination goal for HAT. Gambian sleeping sickness is a tsetse-transmitted disease which, without treatment, usually results in death. Unfortunately no medical prophylaxis exists to prevent infection in humans but curative medicines and vector control options are available. Recently there has been a push to reduce disease burden and a target incidence of 1 reported case per 10,000 people per year is hoped to be achieved in 90% of regions by 2020. Subsequently there is a goal of zero transmission by 2030. Using mathematical modelling, we assessed how different intervention strategies such as improving screening and treatment or introducing vector control can help in achieving these goals in a high endemicity setting. Following model simulation, we predict that improving current screening can reduce the time taken until the elimination targets are met. However it is very unlikely that the reported case target will by achieved by 2020 without additional vector control. We found that vector control has great potential to reduce transmission and, even if it is less effective at reducing tsetse numbers as in other regions, the full elimination goal could still be achieved by 2030. We recommend that control programmes use a combined medical and vector control strategy to help combat sleeping sickness.
Collapse
Affiliation(s)
- Kat S. Rock
- Warwick Infectious Disease Epidemiology Research (WIDER), The University of Warwick, Coventry, UK
- Life Sciences, The University of Warwick, Coventry, UK
- * E-mail:
| | - Steve J. Torr
- Warwick Infectious Disease Epidemiology Research (WIDER), The University of Warwick, Coventry, UK
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Crispin Lumbala
- Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa, Democratic Republic of Congo
| | - Matt J. Keeling
- Warwick Infectious Disease Epidemiology Research (WIDER), The University of Warwick, Coventry, UK
- Life Sciences, The University of Warwick, Coventry, UK
- Mathematics Institute, The University of Warwick, Coventry, UK
| |
Collapse
|
15
|
Kovacic V, Tirados I, Esterhuizen J, Mangwiro CTN, Lehane MJ, Torr SJ, Smith H. We Remember… Elders' Memories and Perceptions of Sleeping Sickness Control Interventions in West Nile, Uganda. PLoS Negl Trop Dis 2016; 10:e0004745. [PMID: 27253367 PMCID: PMC4890773 DOI: 10.1371/journal.pntd.0004745] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Accepted: 05/05/2016] [Indexed: 11/18/2022] Open
Abstract
The traditional role of African elders and their connection with the community make them important stakeholders in community-based disease control programmes. We explored elders’ memories related to interventions against sleeping sickness to assess whether or not past interventions created any trauma which might hamper future control operations. Using a qualitative research framework, we conducted and analysed twenty-four in-depth interviews with Lugbara elders from north-western Uganda. Participants were selected from the villages inside and outside known historical sleeping sickness foci. Elders’ memories ranged from examinations of lymph nodes conducted in colonial times to more recent active screening and treatment campaigns. Some negative memories dating from the 1990s were associated with diagnostic procedures, treatment duration and treatment side effects, and were combined with memories of negative impacts related to sleeping sickness epidemics particularly in HAT foci. More positive observations from the recent treatment campaigns were reported, especially improvements in treatment. Sleeping sickness interventions in our research area did not create any permanent traumatic memories, but memories remained flexible and open to change. This study however identified that details related to medical procedures can remain captured in a community’s collective memory for decades. We recommend more emphasis on communication between disease control programme planners and communities using detailed and transparent information distribution, which is not one directional but rather a dialogue between both parties. African elders are recognized by their communities as important traditional leaders. This role gives them an influential position, which is commonly overlooked by disease control programmes. We focused on sleeping sickness a disease which has a long history of control interventions in our study location in north-western Uganda. We interviewed elders to explore their memories of past interventions. This is important because negative perceptions of past interventions could influence how communities perceive control programmes today. Interviewed elders described sleeping sickness control interventions dating from the 1960s and more recent interventions from 1990s. Invasive diagnostic procedures, toxic side effects of treatment and long hospitalization were remembered from the later interventions. Despite these negative experiences, elders, however, observed recent improvements in treatment and had no negative perceptions of sleeping sickness control programmes. We conclude that community experience with control programmes remains in memories for decades, and we recommend the involvement of elders in planning of these interventions. This would be particularly beneficial because they are aware of the historical contexts of disease control in their environment, have insights into socio-cultural aspects of their communities and may serve as spokespersons between beneficiary community and programme implementers.
Collapse
Affiliation(s)
- Vanja Kovacic
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- * E-mail: ;
| | - Inaki Tirados
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
| | - Johan Esterhuizen
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
| | - Clement T. N. Mangwiro
- Department of Animal Science, Bindura University of Science Education, Bindura, Zimbabwe
| | - Michael J. Lehane
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
| | - Stephen J. Torr
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- Warwick Medical School, University of Warwick, Coventry, United Kingdom
| | - Helen Smith
- Centre for Maternal and Newborn Health, Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
| |
Collapse
|
16
|
Rock KS, Torr SJ, Lumbala C, Keeling MJ. Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo. Parasit Vectors 2015; 8:532. [PMID: 26490248 PMCID: PMC4618948 DOI: 10.1186/s13071-015-1131-8] [Citation(s) in RCA: 74] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 10/02/2015] [Indexed: 12/03/2022] Open
Abstract
Background The virulent vector-borne disease, Gambian human African trypanosomiasis (HAT), is one of several diseases targeted for elimination by the World Health Organization. This article utilises human case data from a high-endemicity region of the Democratic Republic of Congo in conjunction with a suite of novel mechanistic mathematical models to address the effectiveness of on-going active screening and treatment programmes and compute the likely time to elimination as a public health problem (i.e. <1 case per 10,000 per year). Methods The model variants address uncertainties surrounding transmission of HAT infection including heterogeneous risk of exposure to tsetse bites, non-participation of certain groups during active screening campaigns and potential animal reservoirs of infection. Results Model fitting indicates that variation in human risk of tsetse bites and participation in active screening play a key role in transmission of this disease, whilst the existence of animal reservoirs remains unclear. Active screening campaigns in this region are calculated to have been effective, reducing the incidence of new human infections by 52–53 % over a 15-year period (1998–2012). However, projections of disease dynamics in this region indicate that the elimination goal may not be met until later this century (2059–2092) under the current intervention strategy. Conclusions Improvements to active detection, such as screening those who have not previously participated and raising overall screening levels, as well as beginning widespread vector control in the area have the potential to ensure successful and timely elimination. Electronic supplementary material The online version of this article (doi:10.1186/s13071-015-1131-8) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Kat S Rock
- Life Sciences, Warwick University, Coventry, CV4 7AL, UK. .,WIDER, Warwick University, Coventry, CV4 7AL, UK.
| | - Steve J Torr
- WIDER, Warwick University, Coventry, CV4 7AL, UK.,Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK
| | - Crispin Lumbala
- Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Kinshasa, Democratic Republic of Congo
| | - Matt J Keeling
- Life Sciences, Warwick University, Coventry, CV4 7AL, UK.,WIDER, Warwick University, Coventry, CV4 7AL, UK.,Mathematics Institute, Warwick University, Coventry, CV4 7AL, UK
| |
Collapse
|